Home
Disease Knowledge Center Drug Hub Monographs Drug Interactions Pregnancy Drug Safety Drug Recalls & Alerts OTC Navigator
Virtual Simulators Hub Clinical Cases Simulator Nutrition & Macro Calculator
Questo Insights Global Opportunities Hub AI Research Assistant Citation & Reference Generator Scholarships & Essay Planner Visa & Mobility Navigator English Assessment Test
Verified Jobs Board Pharmacy Clearance Pharmacies Directory
Practice Quizzes STEM Academy Toolkits
Medical Case Donations Opportunity Crowdfunding Community Forums Courses Academy
Back to Safety Checker

Sertraline

Selective Serotonin Reuptake Inhibitor (SSRI)

FDA Category C (Risk Cannot Be Ruled Out / Clinical Benefit May Warrant Use) FDA Category C & ACOG Endorsed
Use With Caution — Preferred SSRI in Pregnancy

Sertraline (Zoloft) is the preferred SSRI antidepressant during pregnancy and lactation due to low placental passage and extensive human safety data showing no major risk of structural birth defects.

Medical Disclaimer: This report is for educational and informational purposes only. It does not replace professional medical advice. Always consult your healthcare provider before making any medication decisions during pregnancy.
Pregnancy Summary
Clinical overview for pregnancy

ACOG guidelines endorse sertraline when antidepressant therapy is indicated. Untreated maternal depression carries significant risks (poor prenatal care, low birth weight, postpartum depression).

Trimester Safety Timeline
Safety profile across all three trimesters
1st Trimester
Weeks 1 – 12
Use With Caution

Preferred SSRI. Does not carry the cardiac defect risk associated with paroxetine.

2nd Trimester
Weeks 13 – 27
Use With Caution

Maintains maternal mental health stability.

3rd Trimester
Weeks 28 – Birth
Use With Caution

Minor risk of Poor Neonatal Adaptation Syndrome (PNAS) near delivery (transient jitteriness, self-limiting).

Placental Transfer
Does this medication cross the placenta?
Crosses Placenta
Yes
Transfer Extent
Moderate (Lower umbilical cord blood ratio than paroxetine)

Minimal fetal accumulation at therapeutic doses.

Fetal Risk Assessment
Potential effects on the developing fetus
No Major Structural Teratogenicity

Large prospective studies show no elevated risk of cardiac or major malformations.

Maternal Risk Assessment
Potential maternal side effects during pregnancy
Standard SSRI Side Effects

Nausea or somnolence.

Clinical Recommendation
Professional prescribing guidance
Preferred Antidepressant Option

First-choice SSRI if initiating or continuing antidepressant therapy during pregnancy.

If Already Taken
"I took this before knowing I was pregnant"
1
Do Not Stop Abruptly

Do not discontinue sertraline suddenly. Abrupt SSRI withdrawal risks severe depressive relapse.

Pregnancy Monitoring Protocol
Recommended follow-up and surveillance
Psychiatric & Obstetric Care
  • Monitor maternal mood score
  • Inform labor & delivery team for routine neonatal observation
Safer Alternatives
Active ingredients with better pregnancy safety profiles
fluoxetine
Alternative well-studied SSRI in pregnancy.
Caution
Professional Clinical Notes
Key prescribing considerations and clinical pearls
  • ACOG & APA Guidelines: Sertraline is preferred for perinatal depression.
Patient-Friendly Explanation
In simple, easy-to-understand language
Easy to Understand

Sertraline (Zoloft) is the safest and most recommended medicine for depression or anxiety during pregnancy.

Frequently Asked Questions
Common questions about Sertraline in pregnancy

Yes, sertraline is preferred over paroxetine because it does not carry the risk of heart defects.

Evidence Level
Quality of available safety data
FDA Category C & ACOG Endorsed

American Psychiatric Association & ACOG consensus.

References & Primary Sources
Official U.S. Food & Drug Administration (FDA) PLLR & ACOG Clinical Database
All pregnancy safety evaluations, risk categories, and drug monographs are compiled directly from U.S. FDA Pregnancy and Lactation Labeling Rule (PLLR) standards and approved FDA prescribing labels.
  1. 1
    U.S. Food and Drug Administration (FDA) PLLR — FDA Pregnancy and Lactation Labeling Rule & Approved Prescribing Information Database Last updated: Official FDA Standard
  2. 2
    FDA Center for Drug Evaluation and Research (CDER) — FDA MedWatch & Black Box Warning Database Last updated: Official FDA Standard
  3. 3
    ACOG Practice Bulletins & Guidelines — American College of Obstetricians and Gynecologists Clinical Recommendations Last updated: 2025 Clinical Edition
  4. 4
    Briggs Drugs in Pregnancy and Lactation — Reference Guide to Fetal and Neonatal Risk (12th Edition) Last updated: 2025 Clinical Edition
Search Another Medication

System Notice

Confirm Action